Rituximab
- PDF / 141,122 Bytes
- 1 Pages / 595.245 x 841.846 pts (A4) Page_size
- 94 Downloads / 166 Views
1
S
Cryptococcal meningitis in an elderly patient: case report A 70-year-old man developed cryptococcal meningitis following rituximab administration. The man, who had a 11-year history of rheumatoid arthritis, was admitted with a 1-month history of confusion, weight loss, reduced appetite, difficulty weight bearing and reduced mobility. He was currently receiving methotrexate and prednisolone. Additionally, he had received infliximab for 8 years, with his last dose being administered 7 months prior to admission, and rituximab [route and dosage not stated], which he received 4 months prior to admission. After 2 weeks of hospitalisation, he developed dysarthria, bilateral VIIth nerve palsy, globally reduced power and worsening of his visual acuity. Cryptococcal antigen tests were found to be positive. The man received ambisome and flucytosine. He subsequently made a full recovery and was discharged. Jani M, et al. Cryptococcal Meningitis in Patient with Rheumatoid Arthritis Treated with Infliximab and Rituximab. 12th Annual Congress of the European League Against Rheumatism : abstr. AB0621, 25 May 2011. Available from: URL: 803056508 http://www.eular.org - United Kingdom
0114-9954/10/1358-0001/$14.95 © 2010 Adis Data Information BV. All rights reserved
Reactions 2 Jul 2011 No. 1358
Data Loading...
